logo evfoundry

evFOUNDRY project


Extracellular vesicles (EVs) are natural cell-derived membrane-bound nanoparticles containing proteins and nucleic acids, which are newly recognized as the universal agents of intercellular and inter-organismal communication.

EVs are reshaping our perspective on life sciences, environment and public health. They are under intensive investigation as early disease multi-biomarkers, while EV-based personalized therapeutic agents and vaccines have produced enticing results in early-phase clinical trials.

evFOUNDRY targets the unmet knowledge and technology able to streamline production of therapeutic EVs from sustainable sources, drawing the baseline for future EV bioprocessing, which is necessary for effective EV medical translation and opens to new biogenic nanotechnology.

Network


CSGI
AARHUS UNIVERSITY
UNIVERSITY OF SOUTHAMPTON
LUND UNIVERSITY
HANSABIOMED
Utrecht University

NEWS


2019-10-16
A paper published in Advanced Materials Technologies, highlighting the potential of Electrokinetic Deterministic Lateral Displacement in sorting sub-micron particles

A paper published in Advanced Materials Technologies, highlighting the potential of Electrokinetic Deterministic Lateral Displacement in sorting sub-micron particles

2019-10-16
FET seminar on the evFOUNDRY

FET seminar on the evFOUNDRY

2019-10-16
evFOUNDRY first Review Meeting in Brussels

evFOUNDRY first Review Meeting in Brussels

CONTACTS


Scientific Contacts

Debora Berti

CSGI, Department of Chemistry University of Florence, via della Lastruccia 3, 50019 Florence (Italy)
berti@csgi.unifi.it

Paolo Bergese

CSGI, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
paolo.bergese@unibs.it

Administrative Staff

Daniela Vullo

CSGI, Department of Chemistry University of Florence, via della Lastruccia 3, 50019 Florence (Italy)
evfoundry@csgi.unifi.it

EU
Horizon2020
cookie policy

evFOUNDRY has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801367